Today’s Stocks to Watch: ASML, Morgan Stanley, and Novocure
Key points:
- Luxury stocks, including LVMH, suffer declines in challenging global markets
- Morgan Stanley’s earnings beat estimates, outperforming among stocks
- Novocure wins FDA approval, boosting its shares considerably
LVMH Faces Challenges in Global Markets
LVMH (MC): LVMH, the owner of Louis Vuitton, reported disappointing results and stated it is facing challenges in most markets. Shares of the French company, along with other European luxury stocks, declined sharply.
Morgan Stanley Beats Expectations with Earnings
Morgan Stanley (MS): The bank reported quarterly results that exceeded expectations, with significant growth in investment banking revenues. Morgan Stanley shares rose nearly 2.5% in pre-market trading, boosting investor confidence in its performance.
Equifax, PPG Industries, and Alcoa Results
Equifax (EFX), PPG Industries (PPG), and Alcoa (AA): These companies are expected to release their earnings results after U.S. markets close. Investors will closely monitor their performance, which could shape overall sector sentiment.
ASML and the Fall of Semiconductor Sector Stocks
ASML (ASML): The semiconductor equipment maker continues to decline, with its Amsterdam-listed shares down around 4%. This drop adds to the unfavorable performance of other global semiconductor stocks, including TSMC and Tokyo Electron.
Intel Faces Security Concerns in China
Intel (INTC): The Cybersecurity Association of China has stated that Intel products sold in China should undergo a cybersecurity review, citing concerns that the U.S. manufacturer poses a threat to national security. This has led to a 1.5% drop in Intel’s stock in pre-market trading.
Novocure Celebrates Approval of Its Lung Cancer Treatment
Novocure (NVCR): Novocure shares surged by about a third in after-hours trading after the U.S. Food and Drug Administration approved its Optune Lua portable lung cancer treatment. This approval marks a major milestone for the company and strengthens its position in the market.
J.B. Hunt Surprises with Better-Than-Expected Revenues
J.B. Hunt (JBHT): The transportation and logistics company reported a drop in quarterly revenue, but the decline was less than analysts had expected. As a result, the stock rose nearly 7% in pre-market trading, driven by a better-than-expected performance.